全文获取类型
收费全文 | 3324篇 |
免费 | 172篇 |
国内免费 | 8篇 |
学科分类
医药卫生 | 3504篇 |
出版年
2023年 | 20篇 |
2022年 | 31篇 |
2021年 | 74篇 |
2020年 | 26篇 |
2019年 | 44篇 |
2018年 | 54篇 |
2017年 | 39篇 |
2016年 | 72篇 |
2015年 | 77篇 |
2014年 | 86篇 |
2013年 | 122篇 |
2012年 | 219篇 |
2011年 | 198篇 |
2010年 | 128篇 |
2009年 | 98篇 |
2008年 | 171篇 |
2007年 | 182篇 |
2006年 | 190篇 |
2005年 | 197篇 |
2004年 | 177篇 |
2003年 | 161篇 |
2002年 | 171篇 |
2001年 | 88篇 |
2000年 | 85篇 |
1999年 | 81篇 |
1998年 | 46篇 |
1997年 | 32篇 |
1996年 | 34篇 |
1995年 | 32篇 |
1994年 | 18篇 |
1993年 | 25篇 |
1992年 | 68篇 |
1991年 | 50篇 |
1990年 | 61篇 |
1989年 | 35篇 |
1988年 | 31篇 |
1987年 | 30篇 |
1986年 | 42篇 |
1985年 | 30篇 |
1984年 | 25篇 |
1983年 | 25篇 |
1982年 | 9篇 |
1980年 | 14篇 |
1979年 | 19篇 |
1977年 | 13篇 |
1975年 | 6篇 |
1972年 | 10篇 |
1971年 | 8篇 |
1970年 | 10篇 |
1967年 | 5篇 |
排序方式: 共有3504条查询结果,搜索用时 15 毫秒
51.
Yosuke Ando Takahiro Hayashi Kaori Ito Eri Suzuki Naoyuki Mine Ayumi Miyamoto Miyuki Oya Hidezo Matsuda Ami Isaji Toru Nakanishi Kazuyoshi Imaizumi Tomoyuki Shibata Tatsuyoshi Okada Kazuo Sakurai Kensei Naito Ichiro Uyama Kenji Kawada Hiroshi Takahashi Shigeki Yamada 《Supportive care in cancer》2016,24(2):871-878
52.
53.
54.
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma 总被引:7,自引:3,他引:7 下载免费PDF全文
Tagawa H Suguro M Tsuzuki S Matsuo K Karnan S Ohshima K Okamoto M Morishima Y Nakamura S Seto M 《Blood》2005,106(5):1770-1777
Diffuse large B-cell lymphoma (DLBCL) comprises molecularly distinct subgroups such as activated B-cell-like (ABC) and germinal center B-cell-like (GCB) DLBCLs. We previously reported that CD5(+) and CD5(-)CD10(+) DLBCL constitute clinically relevant subgroups. To determine whether these 2 subgroups are related to ABC and GCB DLBCLs, we analyzed the genomic imbalance of 99 cases (36 CD5(+), 19 CD5(-)CD10(+), and 44 CD5(-)CD10(-)) using array-based comparative genomic hybridization (CGH). Forty-six of these cases (22 CD5(+), 7 CD5(-)CD10(+), and 17 CD5(-)CD10(-)) were subsequently subjected to gene-expression profiling, resulting in their division into 28 ABC (19 CD5(+) and 9 CD5(-)CD10(-)) and 18 GCB (3 CD5(+), 7 CD5(-)CD10(+), and 8 CD5(-)CD10(-)) types. A comparison of genome profiles of distinct subgroups of DLBCL demonstrated that (1) ABC DLBCL is characterized by gain of 3q, 18q, and 19q and loss of 6q and 9p21, and GCB DLBCL is characterized by gain of 1q, 2p, 7q, and 12q; (2) the genomic imbalances characteristic of the CD5(+) and CD5(-)CD10(+) groups were similar to those of the ABC and GCB types, respectively. These findings suggest that CD5(+) and CD5(-)CD10(+) subgroups are included, respectively, in the ABC and GCB types. Finally, when searching for genomic imbalances that affect patients' prognosis, we found that 9p21 loss (p16(INK4a) locus) marks the most aggressive type of DLBCL. 相似文献
55.
Tetsuhide Ito Hironobu Sasano Masao Tanaka R. Yoshiyuki Osamura Iwao Sasaki Wataru Kimura Koji Takano Takao Obara Miyuki Ishibashi Kazuwa Nakao Ryuichiro Doi Akira Shimatsu Toshirou Nishida Izumi Komoto Yukio Hirata Kazuhiko Nakamura Hisato Igarashi Robert T. Jensen Bertram Wiedenmann Masayuki Imamura 《Journal of gastroenterology》2010,45(2):234-243
Background
There have been few epidemiological studies on gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Japan.Methods
We examined the epidemiology of GEP-NETs [pancreatic endocrine tumors (PETs) and gastrointestinal neuroendocrine tumors (GI-NETs)] in Japan in 2005 using a nationwide stratified random sampling method.Results
A total of 2,845 individuals received treatment for PETs. Prevalence was estimated as 2.23/100,000 with an annual onset incidence of 1.01/100,000. Non-functioning tumor (NF)-PET constituted 47.4%, followed by insulinoma (38.2%) and gastrinoma (7.9%). Distant metastases were reported in 21% patients with NF-PETs and occurred more frequently as tumor size increased (>2 cm). Multiple endocrine neoplasia type 1 (MEN-1) was detected in 10% of PETs but only in 6.1% of NF-PETs. NF-PETs were detected incidentally by physical examination in 24% patients. In 2005, an estimated 4,406 patients received treatment for GI-NETs. Prevalence was estimated as 3.45/100,000, with an annual onset incidence of 2.10/100,000. The locations of GI-NETs varied: foregut, 30.4%; midgut, 9.6%; and hindgut, 60.0%. Distant metastases were observed in 6%. Lymph node metastases occurred more frequently as tumor size increased (>1 cm). The frequency of MEN-1 complications was 1%. Physical examination revealed GI-NETs in 44% patients. The frequency of symptomatic GI-NETs was 3.4%. Interestingly, 77.1% of patients with foregut GI-NETs had type A gastritis.Conclusion
Our results show there are large differences in GEP-NETs between Japan and Western nations, primarily due to differences in the presence of MEN-1 in NF-PETs and the location, symptomatic status, and prevalence of malignancy in GI-NETs. 相似文献56.
Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome 总被引:11,自引:1,他引:11 下载免费PDF全文
Kanazawa N Okafuji I Kambe N Nishikomori R Nakata-Hizume M Nagai S Fuji A Yuasa T Manki A Sakurai Y Nakajima M Kobayashi H Fujiwara I Tsutsumi H Utani A Nishigori C Heike T Nakahata T Miyachi Y 《Blood》2005,105(3):1195-1197
Early-onset sarcoidosis (EOS) and inheritable Blau syndrome (BS) share characteristic clinical features of juvenile-onset systemic granulomatosis syndrome that mainly affects skin, joints, and eyes. However, no direct evidence has been shown for the possible common origin of these 2 diseases. Recent discovery of CARD15 mutations in BS families encouraged us to investigate similar CARD15 mutations in EOS patients. Among 10 EOS cases retrospectively collected in Japan, heterozygous missense mutations were found in 9 cases; 4 showed a 1000C>T (R334W in amino acid change) that has been reported in BS, 4 showed novel 1487A>T (H496L), 1538T>C (M513T), 1813A>C (T605P), and 2010C>A (N670K), and 1 case showed double 1146C>G (D382E)/1834G>A (A612T) mutations on different alleles. All 6 of these variants of CARD15 showed increased basal nuclear factor (NF)-kappaB activity. These findings indicate that the majority of EOS and BS cases share the common genetic etiology of CARD15 mutations that cause constitutive NF-kappaB activation. 相似文献
57.
Kohji Nagata Michiko Horinouchi Miyuki Saitou Michiyo Higashi Mitsuharu Nomoto Masamichi Goto Suguru Yonezawa 《Journal of hepato-biliary-pancreatic sciences》2007,14(3):243-254
In this review article, we demonstrate the mucin expression profile in normal tissue, invasive ductal carcinoma (IDC), two subtypes of intraductal papillary–mucinous neoplasm (IPMN dark cell type and IPMN clear cell type), pancreatic intraepithelial neoplasia (PanIN), and mucinous cystic neoplasm (MCN) of the pancreas. In MUC1, there are various glycoforms, such as poorly glycosylated MUC1, sialylated MUC1, and fully glycosylated MUC1. IDCs showed high expression of all the glycoforms of MUC1. IPMNs dark cell type showed no expression or low expression of all the glycoforms of MUC1. IPMNs clear cell type showed low expression of poorly glycosylated MUC1, but expression of sialylated MUC1 and fully glycosylated MUC1. Expression of MUC2 was negative in IDCs, high in IPMNs dark cell type and low in IPMNs clear cell type. MUC5AC was highly expressed in IDCs, IPMNs dark cell type, and IPMNs clear cell type. MUC6 expression was higher in IPMNs clear cell type than in IDCs and IPMNs dark cell type. Our recent study demonstrated that high expression of MUC4 in IDCs is correlated with a poor outcome for patients. In PanINs, expression of both MUC5AC and MUC6 are an early event, whereas up-regulation of MUC1 is a late event. MCNs do not look as if they will show a specific mucin expression profile according to the literature review. 相似文献
58.
59.
Mihoko Kato Yoshiharu Ihara Eiko Nakata Miyuki Miyazawa Michiyo Sasaki Tsukasa Kodaira 《Food and Agricultural Immunology》2007,18(3-4):179-187
Antibacterial reagents, especially quinolones, are widely used in animals and humans, and have caused serious problems to human health because of their residual contaminants in food. In order to screen for different kinds of newquinolones at the same time, a sensitive and specific enzyme-linked immunoassay (ELISA) has been developed. The anti-enrofloxacin monoclonal antibody was selected because of its ability to react with structurally related newquinolones in organic solvent. The antibody has 100% cross-reactivity with norfloxacin, ciprofloxacin and other newquinolones at 50% inhibition of control values IC50, but not with nitroflazone, sulphadimethoxine. The lowest detection limit of this ELISA was 0.7 ng/ml (ppb) when enrofloxacin was used as the calibrator. Eel extracts were spiked with enrofloxacin and the average recoveries at 10, 50, 100 ng/ml were 98, 102 and 91%, respectively. The proposed ELISA is a useful method for the practical microquantitation of various newquinolones in biological and environmental specimens. 相似文献
60.
Cyclic Stretch Augments Production of Neutrophil Chemokines,Matrix Metalloproteinases,and Activin A in Human Endometrial Stromal Cells 下载免费PDF全文